Read More Pharma Industry News Alnylam, Dicerna form RNAi collaboration for alpha-1 liver disease Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are joining forces to develop and commercialize ribonucleicacid interference therapies (RNAi therapeutics) for… bypharmanewsdailyApril 8, 2020
